Inventor · disambiguated record
Soumojeet Ghosh
Also filed as: GHOSH SOUMOJEET · LINDENHURST GHOSH
20 granted patents·13 pending applications·158 citations·filing 1997–2016
95Inventor score
Top patents by PatentIndex Score
33 records- 0195US8268349B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2012·Granted Sep 18, 2012·15 cites·7 claims
- 0290US7432294B2Pharmaceutical formulationsABBOTT LAB·Filed 2006·Granted Oct 7, 2008·5 cites·25 claims
- 0389US8377952B2Solid pharmaceutical dosage formulationABBOTT LAB·Filed 2005·Granted Feb 19, 2013·4 cites·35 claims
- 0488US8399015B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2011·Granted Mar 19, 2013·3 cites·31 claims
- 0588US8025899B2Solid pharmaceutical dosage formABBOTT LAB·Filed 2004·Granted Sep 27, 2011·14 cites·14 claims
- 0684US8691878B2Solid pharmaceutical dosage formABBVIE INC·Filed 2012·Granted Apr 8, 2014·2 cites·20 claims
- 0783US6232333B1Pharmaceutical compositionABBOTT LAB·Filed 1997·Granted May 15, 2001·50 cites·16 claims
- 0882US8333990B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2010·Granted Dec 18, 2012·1 cites·23 claims
- 0980US7141593B1Pharmaceutical formulationsABBOTT LAB·Filed 2000·Granted Nov 28, 2006·10 cites·26 claims
- 1078US6911214B2Flavoring systems for pharmaceutical compositions and methods of making such compositionsABBOTT LAB·Filed 2001·Granted Jun 28, 2005·6 cites·1 claims
- 1178US6284767B1Retroviral protease inhibiting compoundsABBOTT LAB·Filed 1998·Granted Sep 4, 2001·14 cites·98 claims
- 1277US8486983B2Self-emulsifying formulations of CETP inhibitorsSHETH AGAM R·Filed 2006·Granted Jul 16, 2013·6 cites·7 claims
- 1376US8414921B2Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metforminKAMALI ASHKAN·Filed 2006·Granted Apr 9, 2013·6 cites·28 claims
- 1474US7981911B2Pharmaceutical formulationsABBOTT LAB·Filed 2008·Granted Jul 19, 2011·1 cites·14 claims
- 1572US2014179721A1Solid pharmaceutical dosage formABBVIE INC·Filed 2014·Application pending·0 cites
- 1671US2008299203A1Solid Pharmaceutical Dosage FormulationROSENBERG JOERG·Filed 2008·Application pending·0 cites
- 1770US8501219B2Flavoring systems for pharmaceutical compositions and methods of making such compositionsALANI LAMAN·Filed 2010·Granted Aug 6, 2013·2 cites·29 claims
- 1868US8895051B2Flavoring systems for pharmaceutical compositions and methods of making such compositionsABBVIE INC·Filed 2013·Granted Nov 25, 2014·0 cites·31 claims
- 1965US8309613B2Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2010·Granted Nov 13, 2012·0 cites·18 claims
- 2063US2007249643A1Solid pharmaceutical dosage formROSENBERG JOERG·Filed 2007·Application pending·0 cites
- 2162US6458818B1Pharmaceutical compositionABBOTT LAB·Filed 1999·Granted Oct 1, 2002·17 cites·30 claims
- 2262US2013004578A1Solid Pharmaceutical Dosage FormulationABBVIE INC·Filed 2012·Application pending·0 cites
- 2358US2003032619A1Pharmaceutical compositionFiled 2002·Application pending·0 cites
- 2458US2011165239A1Pharmaceutical compositions of atorvastatinALANI LAMAN·Filed 2009·Application pending·0 cites
- 2557US2008181948A1Solid pharmaceutical dosage formulationsABBOTT LAB·Filed 2007·Application pending·0 cites
- 2655US2005191324A1Flavoring systems for pharmaceutical compositions and methods of making such compositionsFiled 2005·Application pending·0 cites
- 2747US2016136099A1Method for producing monolithic tabletsABBVIE INC·Filed 2016·Application pending·0 cites
- 2844US2005048112A1Solid pharmaceutical dosage formFiled 2003·Application pending·0 cites
- 2942US9278052B2Method for producing monolithic tabletsGHOSH SOUMOJEET·Filed 2011·Granted Mar 8, 2016·0 cites·4 claims
- 3042US2009136570A1Taste-Masked Tablets and GranulesREGE BHAGWANT·Filed 2007·Application pending·0 cites
- 3137US6521651B1Pharmaceutical compositionABBOTT LAB·Filed 1999·Granted Feb 18, 2003·2 cites·11 claims
- 3233US2009123538A1Angiotensin II Receptor AntagonistsALANI LAMAN L·Filed 2006·Application pending·0 cites
- 3327US2012202838A1Drug formulationsGHOSH SOUMOJEET·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →